Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

17 results
Display

Golimumab Therapy in Ulcerative Colitis

Moon W

Ulcerative colitis is a chronic inflammatory condition of the colon, characterized by diffuse mucosal inflammation and blood-mixed diarrhea. The main treatment has been 5-aminosalicylic acid, steroid, thiopurine, and anti-tumor necrosis...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Cumulative Colectomy Rate in Patients with Cytomegalovirus-Positive Ulcerative Colitis

Ozturk K, Demirci H, Kantarcioglu M, Uygun A, Bagci S

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Current and Emerging Biologics for Ulcerative Colitis

Park SC, Jeen YT

Conventional medical treatment for ulcerative colitis can have limited efficacy or severe adverse reactions requiring additional treatment or colectomy. Hence, different biological agents that target specific immunological pathways are being...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Understanding the Role of Adalimumab in the Treatment of Moderately to Severely Active Ulcerative Colitis

Kim JH, Cheon JH

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Reply: Careful Assessment Is Needed in Patients with Ulcerative Colitis with Evidence of Cytomegalovirus Reactivation

Kim YS, Kim JS

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Does the Cyclosporine Still Have a Potential Role in the Treatment of Acute Severe Steroid-Refractory Ulcerative Colitis?

Eun CS, Han DS

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Efficacy and Safety of a Tofacitinib in the Treatment of Active Ulcerative Colitis

Seo GS

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Infliximab versus Cyclosporine Treatment for Severe Corticosteroid-Refractory Ulcerative Colitis: A Korean, Retrospective, Single Center Study

Kim EH, Kim DH, Park SJ, Hong SP, Kim TI, Kim WH, Cheon JH

BACKGROUND/AIMS: In patients with corticosteroid-refractory ulcerative colitis (UC), cyclosporine or infliximab may be added to the treatment regimen to induce remission. Here, we aimed to compare the efficacy of cyclosporine...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Guidelines for the Management of Ulcerative Colitis

Choi CH, Kim YH, Kim YS, Ye BD, Lee KM, Lee BI, Jung SA, Kim WH, Lee H, IBD Study Group of the Korean Association for the Study of Intestinal Diseases

Ulcerative colitis (UC) is a chronic inflammatory bowel disorder characterized by a relapsing and remitting course. The quality of life can decreases significantly during exacerbations of the disease. The incidence...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The immune-stimulating peptide WKYMVm has therapeutic effects against ulcerative colitis

Kim SD, Kwon S, Lee SK, Kook M, Lee HY, Song KD, Lee HK, Baek SH, Park CB, Bae YS

  • KMID: 2154259
  • Exp Mol Med.
  • 2013 Sep;45(9):e40.
In this study, we examined the therapeutic effects of an immune-stimulating peptide, WKYMVm, in ulcerative colitis. The administration of WKYMVm to dextran sodium sulfate (DSS)-treated mice reversed decreases in body...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Efficacy and Safety of Adalimumab in Moderately to Severely Active Cases of Ulcerative Colitis: A Meta-Analysis of Published Placebo-Controlled Trials

Zhang ZM, Li W, Jiang XL

BACKGROUND/AIMS: To evaluate the efficacy and safety of adalimumab (ADA) in moderately to severely active ulcerative colitis (UC) patients who are unresponsive to traditional therapy. METHODS: Electronic databases, including the PubMed,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Pathogenesis and Treatment of Intestinal Behcet's Disease

Lee CK, Kim HJ

  • KMID: 782880
  • Korean J Gastroenterol.
  • 2007 Jul;50(1):3-8.
Intestinal Behcet's disease (BD) refers to colonic ulcerative lesions documented by objective measures in patients with BD. Although the causes of intestinal BD are unknown, genetic, environmental, and immunological factors...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Application of Multidetector-row CT for Pancreas Imaging

Kim MJ

  • KMID: 782775
  • Korean J Gastroenterol.
  • 2006 Oct;48(4):256-262.
Recent development of multidetector-row CT (MDCT) has improved the z-axis resolution of spiral CT and provided the isotropic imaging capability, which enables various postprocessing technique without degradating the quality of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
COX-2 Inhibitors in Inflammatory Bowel Disease: Friends or Foes?

Park YS

  • KMID: 937929
  • Korean J Gastroenterol.
  • 2007 Dec;50(6):350-355.
The cyclooxygenase (COX) is a key enzyme in the coversion of arachidonic acid to prostaglandins. COX-1 is constitutively expressed and is a critical housekeeping gene, whereas COX-2 is rapidly upregulated...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Transmesocolic Hernia in Elderly Person without a History of Operation

Park HS, Kim JI, Kim MS, Kim SS, Cho SH, Park SH, Han JY, Kim JK

  • KMID: 782780
  • Korean J Gastroenterol.
  • 2006 Oct;48(4):286-289.
Internal hernia is defined as the herniation of viscera through an anatomic or pathologic opening within the boundaries of peritoneal cavity. Transmesocolic hernia, a subtype of internal hernia, has a...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Clinical Use of Measuring Trough Levels and Antibodies against Infliximab in Patients with Pediatric Inflammatory Bowel Disease

Choi SY, Kang B, Lee JH, Choe YH

BACKGROUND/AIMS: The clinical use of measuring infliximab (IFX) trough levels (TLs) and antibodies against IFX (ATIs) in patients with pediatric inflammatory bowel disease (IBD) remains unclear. We propose measuring these...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Risk of Tuberculosis in Korean Patients with Inflammatory Bowel Disease Receiving Tumor Necrosis Factor-alpha Blockers

Byun JM, Lee CK, Rhee SY, Kim HJ, Kim JW, Shim JJ, Jang JY

The aims of this study were to assess the risk of tuberculosis (TB) and the status of latent tuberculosis infection (LTBI) in Korean patients with inflammatory bowel disease (IBD) receiving...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr